Laryngeal muscle activity during nasal high frequency oscillatory ventilation in non-sedated newborn lambs by Samson, Nathalie et al.
Laryngeal muscle activity during nasal high frequency oscillatory 1 
ventilation in non-sedated newborn lambs 2 
 3 
Mohamed Amine Hadj-Ahmed, Nathalie Samson, Charlène Nadeau, Nadia Boudaa, 4 
Jean-Paul Praud 5 
Neonatal Respiratory Research Unit, Departments of Pediatrics and Physiology, 6 
Université de Sherbrooke, QC, Canada, J1H 5N4 7 
 8 
 9 
Running head: High frequency ventilation and laryngeal muscle EMG  10 
 11 
Address for correspondence and proofs: 12 
Jean-Paul Praud MD PhD    Phone: (819) 346-1110, ext 14851 13 
Departments of Pediatrics and Physiology Fax: (819) 564-5215 14 
Université de Sherbrooke    email: Jean-Paul.Praud@USherbrooke.ca 15 
J1H 5N4, QC Canada 16 
17 
ABSTRACT 18 
Background - We have previously shown that nasal pressure support ventilation (nPSV) 19 
can lead to an active inspiratory laryngeal narrowing in lambs. This, in turn, can limit 20 
lung ventilation and divert air into the digestive system, with potentially deleterious 21 
consequences. On the other hand, nasal high frequency oscillatory ventilation (nHFOV) 22 
is particularly attractive in newborns, especially since, unlike nPSV, it does not require 23 
synchronization with the patient’s inspiratory efforts. 24 
Objectives - The main aim of the present study was to test the hypothesis that glottal 25 
constrictor muscle activity (EMG) does not develop during nHFOV. A secondary 26 
objective was to study laryngeal EMG during nHFOV-induced central apneas. 27 
Methods - Polysomnographic recordings were performed in seven non-sedated lambs 28 
which were ventilated with increasing levels of nPSV and nHFOV at both 4 and 8 Hz, in 29 
random order. States of alertness, diaphragm and glottal muscle EMG, SpO2 and 30 
respiratory movements were continuously recorded. 31 
Results - While phasic inspiratory glottal constrictor EMG appeared with increasing 32 
nPSV levels in 6 out of 7 lambs, it was never observed with nHFOV. In addition, nHFOV 33 
at 4Hz dramatically inhibited central respiratory drive in 4/7 lambs, with 64 to 100% of 34 
recording time spent in central apnea in 3 lambs. No glottal constrictor EMG was 35 
observed during these central apneas. 36 
Conclusion - nHFOV does not induce glottal constrictor muscle EMG in non-sedated 37 
newborn lambs, in contrast to nPSV. This may be an additional advantage of nHFOV 38 
relative to nPSV. 39 
KEYWORDS: Nasal pressure support ventilation, nasal high frequency oscillatory 40 
ventilation, polysomnography, central apnea, quiet sleep. 41 
42 
INTRODUCTION 43 
Non-invasive ventilation is increasingly used in the newborns to reduce the duration of 44 
endotracheal mechanical ventilation and its associated complications. Common 45 
indications in infants for non-invasive ventilation include respiratory distress syndrome, 46 
apneas of prematurity and respiratory syncytial virus infection [1,2]. 47 
In addition to the various conventional non-invasive ventilation modalities available, 48 
nHFOV is attracting increasing interest. First, it is well established that endotracheal 49 
HFOV is associated with less lung injury than conventional mechanical ventilation in 50 
animal studies [3], as well as with superior lung function at 11 to 14 years of age in 51 
extremely prematurely-born children [4]. Secondly, nHFOV does not require 52 
synchronization with the patient’s respiratory efforts, a strong advantage in the newborn 53 
[5]. Thirdly, case reports in newborns, as well as bench studies using lung models, have 54 
shown that nasopharyngeal HFOV is highly effective in eliminating CO2 [6,7]. Finally, 55 
animal data suggest that nasopharyngeal HFOV decreases lung inflammation and 56 
improves alveolarization compared to conventional ventilation [8].  57 
However, an important consideration when using a nasal interface is the interposition of 58 
the larynx between the ventilator and the lungs. For instance, we have previously shown 59 
that nPSV can induce an active inspiratory laryngeal narrowing [9-11]. The latter may 60 
promote patient-ventilator asynchrony and limit lung ventilation [12], as well as divert the 61 
insufflated gas into the esophagus, exposing the infant to gastric distension and further 62 
respiratory compromise [13]. Knowing whether nHFOV can induce active laryngeal 63 
narrowing is certainly of interest before contemplating a more widespread use in 64 
newborns. Hence, the primary aim of our study was to assess the effects of nHFOV on 65 
laryngeal EMG in non-sedated newborn lambs, testing the hypothesis that glottal 66 
narrowing does not develop during nHFOV.  67 
Animal studies have demonstrated that endotracheal HFOV can inhibit spontaneous 68 
breathing and induce central apneas [14]. In addition, we have repeatedly shown the 69 
consistent presence of active glottal closure throughout central apneas in lambs [15]. 70 
Consequently, the secondary aims of the present study were to verify whether i) 71 
oscillation frequency changes during nHFOV induces central apneas and ii) active 72 
laryngeal closure is present during these nHFOV-induced central apneas. 73 
74 
MATERIAL AND METHODS 75 
Animals 76 
Experiments were conducted in seven term lambs aged from 4 to 5 days and weighing 77 
80 4.1 kg (SD 0.7). The study was approved by the ethics committee for animal care 78 
and experimentation of the Universite de Sherbrooke (# 037-10). 79 
 80 
Chronic instrumentation 81 
Surgery was performed under general anesthesia for chronic instrumentation (see 11 for 82 
details). We measured the electrical activity of the thyroarytenoid (EAta, a glottal 83 
constrictor), cricothyroid (EAct, a laryngeal dilator) and sternal diaphragmatic (EAdi) 84 
muscles, states of alertness, arterial blood gases, respiratory movements (inductance 85 
plethysmography), oxygen hemoglobin saturation (SpO2) and mask pressure (Pmask). 86 
The raw EMG signals were sampled at 1000 Hz, band-pass filtered (30-300 Hz), 87 
rectified and moving time averaged (100 ms). All signals were transmitted via 88 
radiotelemetry and recorded using AcqKnowledge software (Santa Barbara, CA). 89 
 90 
Design of study 91 
Following 48 hours of rest, polysomnographic recordings were performed without 92 
sedation, while lambs were lying on their left side. Nasal PSV triggered by flow 93 
(Siemens Servo 300) and nHFOV (Sensormedics 3100a, Cardinal Health, Canada) 94 
were delivered via a custom-made nasal mask.  95 
Following a first recording without ventilatory support (nCPAP 0), a nasal CPAP of 4 96 
cmH2O was applied. Then, nPSV and nHFOV were applied in a random order, using a 97 
step-by-step increase in ventilation. Three levels of nPSV (6, 11 and 16 cmH2O above a 98 
PEEP of 4 cmH2O) were studied [9-11]. For nHFOV, preliminary experiments 99 
determined that while regular respiration was present at 8 Hz, respiration was frequently 100 
inhibited at 4 Hz. Hence, oscillatory frequency was first set at 8 Hz, mean airway 101 
pressure (MAP) at 8 cmH2O and inspiratory time at 33% [7,16]; thereafter, power levels 102 
were progressively increased to match nPSV levels. Accordingly, nHFOV-8Hz-103 
corresponded to the power level (ΔP-8Hz-1) at which abdominal vibrations were 104 
apparent, whereas nHFOV-8Hz-2 and nHFOV-8Hz-3 corresponded to ΔP-8Hz-1 + 10 and 105 
+ 20 cmH2O. Finally, nHFOV study was completed by reducing the oscillatory frequency 106 
to 4 Hz at nHFOV-4Hz-3. At least five minutes of quiet sleep (QS) were recorded in each 107 
condition. 108 
 109 
Data analysis 110 
States of alertness: Standard electrophysiological and behavioral criteria were used to 111 
recognize states of alertness. Only periods of QS were analyzed for laryngeal EMG with 112 
nPSV and nHFOV. However, for the second aims of our study, all states of alertness 113 
were analyzed. 114 
Respiratory dependent variables 115 
At each ventilatory level, the first 60 seconds of continuous QS were analyzed. The 116 
percentages of breaths with inspiratory phasic EMG of the TA (%inspiEAta) or CT 117 
(%inspiEAct) were calculated [11]. The inspiratory phasic EAdi and EAct amplitudes 118 
were expressed as a percentage of EAdi or EAct values averaged over 60 seconds 119 
during nCPAP 0 (respectively %ampliEAdi and %ampliEAct). Finally, the minute-EAdi 120 
(inspiratory phasic EAdi x respiratory rate) was calculated. Values were averaged over 121 
60 seconds. Blood gases were measured at the end of each ventilatory level. A central 122 
apnea was defined as at least two missed breaths. 123 
 124 
Statistical analysis 125 
Results were averaged in each lamb, then averaged for the 7 lambs as a whole, and 126 
described as means and SD. The Friedman test followed by the Wilcoxon signed rank 127 
test was used for all analyses (SPSS statistics 20). Differences were considered 128 
significant if P < 0.05. In addition, a P < 0.1, indicative of a tendency towards a 129 
significant difference, was fully considered in the discussion. 130 
131 
RESULTS 132 
Experiments were completed in all lambs. Sample tracings obtained in one lamb are 133 
shown in figure 1. 134 
 135 
Alterations in respiration with increasing levels of nPSV and nHFOV at 8Hz 136 
A significant decrease in respiratory rate (RR) was observed with increasing levels of 137 
nPSV and nHFOV-8Hz (Table 1). Overall, RR was decreased with nPSV 20/4 compared 138 
to nPSV 15/4 (P = 0.03), nPSV 10/4 (P = 0.02) and nCPAP 4 (P = 0.08). While no 139 
significant differences were observed between the various nHFOV-8Hz conditions (P = 140 
0.2), RR was decreased in six lambs with nHFOV-8Hz-3 compared to MAP 8. A 141 
significant decrease in %ampliEAdi (P = 0.05) and minute-EAdi (P = 0.04) (n = 4) was 142 
observed with increasing nPSV level, unlike nHFOV (Figure 2). 143 
While PaCO2 did not decrease during nHFOV (P = 0.9), PaCO2 was significantly 144 
decreased at the highest nPSV level (20/4) compared to nCPAP 4, nPSV 10/4 and 145 
nPSV 15/4 (P between 0.02 and 0.04). No alteration of PaO2 was observed (Table 1). 146 
 147 
Laryngeal muscle activity with nPSV and nHFOV at 8Hz 148 
Similarly to our previous studies, phasic inspiratory EAta (glottal constrictor) appeared 149 
with increasing levels of nPSV in 6 of 7 lambs (Table 2). In addition, %inspiEAta 150 
increased in proportion with nPSV levels (P = 0.01) (Figure 2). Simultaneously, a 151 
decrease in %inspiEAct and %ampliEAct (glottal dilator) was apparent with increasing 152 
levels of nPSV, although it did not reach statistical significance (respectively P ≥ 0.6) 153 
(Figure 2). Conversely to nPSV, inspiEAta was never observed at any nHFOV-8Hz level 154 
in any of the lambs (Table 2, Figure 2). Simultaneously, no significant alteration of 155 
baseline %inspiEAct and %ampliEAct activity was apparent with nHFOV-8Hz (Figure 2). 156 
 157 
Effects of nHFOV at 4Hz 158 
Respiratory inhibition 159 
The effects of a decrease in oscillatory frequency from 8 to 4 Hz are displayed in figure 160 
1 and Table 3. Respiratory efforts were severely inhibited (> 60% recording time spent in 161 
apnea) in 3 of 7 lambs, including near total abolition of respiration throughout the 162 
recording in 2 lambs. Overall, the mean percentage of total time spent in apnea was 163 
higher at nHFOV-4Hz-3 than nHFOV-8Hz-3 (P = 0.02). In all lambs, regular respiration 164 
resumed when nHFOV-4Hz-3 was ceased. Of note, despite the severe respiratory 165 
inhibition observed at nHFOV-4Hz-3, PaCO2 remained above 35 mmHg for all lambs. In 166 
addition, PaCO2 was not different at nHFOV-8Hz-3 and nHFOV-4Hz-3 (P = 0.4). Finally, the 167 
2 lambs with the most marked decrease in PaCO2 from MAP 8 to nHFOV-4Hz-3 (lambs 2 168 
and 5) had no respiratory inhibition at nHFOV-4Hz-3. Hence, overall, higher respiratory 169 
inhibition at nHFOV-4Hz-3 compared to nHFOV-8Hz-3 was clearly not linked to a lower 170 
PaCO2 in the former condition. 171 
Laryngeal muscle activity 172 
As documented during nHFOV-8Hz, no inspiratory or expiratory EAta was observed at 173 
nHFOV-4Hz-3 during periods with respiratory efforts. Finally, no continuous EAta was 174 
observed during any central apnea induced by nHFOV-4Hz-3. 175 
 176 
177 
DISCUSSION 178 
This study demonstrates for the first time that in contrast to nPSV, nHFOV at 8 Hz or 4 179 
Hz did not induce phasic inspiratory glottal constrictor activity in any lamb. 180 
Simultaneously, phasic inspiratory glottal dilator activity did not decrease during nHFOV, 181 
unlike nPSV. In addition, nHFOV at 4Hz dramatically inhibited spontaneous breathing in 182 
half of the lambs, while nHFOV at 8Hz was responsible for a lesser decrease in 183 
respiratory rate. 184 
 185 
Respiration with nHFOV at 8 Hz 186 
The use of HFOV via a nasopharyngeal tube has been reported in newborns [5,17,18]. 187 
Clinical interest in non-invasive HFOV stems from the fact that it does not require 188 
synchronization with the patient’s breathing efforts [5]. In addition, HFOV is effective in 189 
eliminating CO2 [6,7,19], while inducing less lung injury [3] and ensuring better alveolar 190 
development [8]. 191 
In agreement with observations in newborn infants [20], our results confirm that, aside 192 
from periods of prolonged central apneas which were especially prominent at 4 Hz (see 193 
infra), newborn lambs maintained regular respiration during nHFOV, with no significant 194 
modifications of baseline diaphragm activity. 195 
Overall, blood gases were largely unaltered. The absence of hypocapnia may seem 196 
surprising, due to the reported ability of nHFOV to decrease CO2 in newborn infants 197 
[6,7,19]. However, administration of nHFOV in these studies was for much longer 198 
periods than in our study, and the decrease in PaCO2 was not apparent in the first two 199 
hours [7]. Further explanation may come from the absence of hypercapnia before 200 
starting nHFOV in our lambs (except in one lamb), and the possibility of CO2 re-201 
inspiration [21]. 202 
 203 
Laryngeal muscle activity during nPSV and nHFOV 204 
The present study confirms our previous results in lambs that inspiEAta often develops 205 
against ventilator insufflations during nPSV, likely from the stimulation of 206 
bronchopulmonary receptors [9-11]. In contrast to nPSV, phasic inspiEAta was absent 207 
during nHFOV. While high amplitude changes in pressure, flow and volume are 208 
transmitted to lower airways and lungs during ventilator insufflations in nPSV, the 209 
situation is very different in nHFOV, where forced oscillations of very small volumes are 210 
superimposed on a constant positive pressure. Hence, differences in pattern stimulation 211 
of bronchopulmonary receptors may explain the differences in EAta activity in nPSV vs. 212 
nHFOV. In addition, while stimulation of upper airway mechanoreceptors did not appear 213 
to be involved in the activation of glottal constrictor muscles in nPSV [10], the reported 214 
oscillatory activation of these mechanoreceptors may play a role in preventing inspiEAta 215 
in nHFOV [22-24]. Finally, given that inspiEAta during nPSV appears related to a 216 
decrease in PaCO2 in some lambs [11], the absence of hypocapnia in nHFOV may be 217 
involved in the absence of inspiEAta. 218 
A few studies have suggested that HFOV may stimulate active upper airway opening 219 
[22,23]. In the present study however, no modification of inspiratory glottal dilator activity 220 
(EAct) was apparent with nHFOV. These results suggest that nHFOV prevents active 221 
laryngeal closure also by maintaining inspiratory EAct. 222 
 223 
Respiratory inhibiting effect 225 of nHFOV at 4Hz 224 
We observed that decreasing the oscillatory frequency from 8 to 4 Hz without altering 225 
MAP or Vt dramatically inhibited central inspiratory drive in almost all animals, without 226 
inducing hypocapnia. Similar respiratory inhibition reported with endotracheal HFOV has 227 
been linked to an increase in vagal pulmonary stretch receptor activity [14] as well as 228 
thoracic wall afferent activity [25]. While alterations of oscillation frequency, stroke 229 
volume or PaCO2 have been deemed responsible for respiratory inhibition, our results 230 
show that alteration of frequency only in nHFOV can be sufficient. 231 
Laryngeal muscle activity during induced apneas 232 
Surprisingly, no continuous EAta was observed during any central apnea induced by 233 
nHFOV at 4Hz. Our studies have consistently shown the presence of active glottal 234 
closure throughout neonatal central apneas under various conditions. The latter include 235 
spontaneous apneas in full-term and preterm lambs, hypocapnic induced apneas, as 236 
well as apneas during anoxic gasping [15]. To date, nHFOV is the only condition during 237 
which continuous active glottal closure was absent during central apneas in our neonatal 238 
ovine models. This cannot be related to the absence of hypocapnia since the latter was 239 
obviously absent in anoxic gasping [26]. Hence, it is rather related to afferent messages 240 
originating from airway and/or thoracic wall mechanoreceptors stimulated by the 241 
constant positive pressure (MAP at 8 cmH2O) and/or ventilator oscillations. Again, the 242 
effect of high frequency oscillations in opening the upper airways may explain the 243 
absence of EAta during nHFOV-induced central apneas [22-24]. 244 
245 
CONCLUSION 246 
This is the first study documenting the effect of nHFOV on laryngeal muscle function and 247 
central inspiratory drive. In non-sedated newborn lambs, and contrary to nPSV, phasic 248 
inspiratory glottal constrictor activity is absent and phasic inspiratory glottal dilator 249 
activity is maintained during nHFOV. Moreover, nHFOV at 4 Hz often dramatically 250 
inhibits central inspiratory drive, even in the absence of alveolar hyperventilation. 251 
Further studies are needed to clarify the exact reflex mechanism underlying this 252 
respiratory inhibition. We propose that our results are relevant in helping the clinician 253 
choose the optimal nasal ventilatory modality for a given newborn in need of ventilatory 254 
support. 255 
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FIGURE LEGENDS 339 
 340 
Figure 1: Laryngeal muscle activity during nasal support ventilation (nPSV) and nasal 341 
high frequency oscillatory ventilation (nHFOV) at 8 Hz during quiet sleep in one lamb. In 342 
contrast to nPSV 15/4, nHFOV-8Hz-3 does not induce phasic inspiratory glottal constrictor 343 
electrical activity. Abbreviations from top to bottom: EAta, electrical activity (EA) of the 344 
thyroarytenoid muscle (ta, a glottal constrictor); ∫EAta, moving time averaged EAta; 345 
EADi, EA of the diaphragm muscle; Pmask, mask pressure; Vlung, lung volume 346 
variations, given by the sum signal of the respiratory inductance plethysmography 347 
(inspiration upwards); I, inspiration; e, expiration. Arterial CO2 pressure (PaCO2) is given 348 
in mmHg and heart rate (HR) in bpm. In addition to the inspiratory phasic EAta, which 349 
consistently occurred in lambs with nPSV in the present study as well as in our previous 350 
studies, expiratory phasic EAta was also uniquely observed in this lamb. Such expiratory 351 
EAta was very rarely observed in our previous studies on nPSV. 352 
 353 
Figure 2: Glottal constrictor (EAta), glottal dilator (EAct) and diaphragmatic muscle 354 
electrical activity (EAdi) during nPSV and nHFOV-8Hz. A) Percentage of ventilatory 355 
cycles with EAta (%inspiEAta) for 6 lambs. B) Inspiratory phasic EAct amplitude 356 
(%ampliEAct) calculated for each inspiration and expressed as a percentage of EAct 357 
values during nCPAP 0 for 5 lambs C) Inspiratory phasic EAdi amplitude calculated for 358 
each inspiration and expressed as a percentage of EAdi values during nCPAP 0 359 
(%ampliEAdi), as well as minute-EAdi for 4 lambs. Increasing nPSV levels, as opposed 360 
to nHFOV, led to a progressive increase in %inspiEAta. While not statistically significant, 361 
a decrease in %ampliEAct was apparent with increasing levels of nPSV, whereas this 362 
activity remained unchanged during nHFOV. Finally, a significant decrease in both 363 
%ampliEAdi and minute-EAdi was observed with increasing nPSV level, unlike nHFOV 364 
mode. Underlined exponent: P < 0.05; normal font exponent: P < 0.1 ∞: vs. CPAP 0; †: 365 
vs. PSV 10/4.; ℓ: vs. PSV 15/4. 366 
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